In two days!
Join the virtual dialogue: “50 Years of the WHO Essential Medicines List: What Has Section 2 of the WHO Model List Meant for Equitable Access to Palliative Care Medicines?”
📅 October 15
Register now 👉🏻 l.iahpc.org/dgj?b
@iahpc.org
@iahpc.orgIn two days!
Join the virtual dialogue: “50 Years of the WHO Essential Medicines List: What Has Section 2 of the WHO Model List Meant for Equitable Access to Palliative Care Medicines?”
📅 October 15
Register now 👉🏻 l.iahpc.org/dgj?b
@medicinespatentpool.org🇩🇪 See you at #WHS2026 in Berlin!
MPP's Charles Gore, Serge Sagodira, Natacha Debbane and Mila Maistat will be there to discuss partnerships, voluntary licensing and access to medicines.
Get in touch if you'd like to connect. 🤝🌍
@healthcaretoday.bsky.socialCaroline Donoghue, access manager at blood cancer charity Myeloma UK, gives the five steps that are needed for people to have access to the most effective drugs and treatments.
@itpc.bsky.socialMellouk's call: access planning from the R&D stage. Broad, transparent voluntary licensing. Technology transfer. Rapid registration. Generic competition. Public pricing. And when licenses fail, TRIPS flexibilities must stay on the table.
